Antibody Inhibition of Binding of WEHI78/24 to Inflamed HEV
| Antibody . | Antigen . | Binding . |
|---|---|---|
| . | . | (% of medium control)* . |
| MEL-14 | L-selectin | 19 ± 4 |
| PS/2 | α4 integrin | 94 ± 12 |
| FD441.8 | CD11a | 63 ± 6 |
| M1/70 | CD11b | 45 ± 6 |
| M18/2.a.8 | CD18 | 56 ± 15 |
| L11 | CD43 | 29 ± 6 |
| RB6-8C5 | PMN | 112 ± 23 |
| 30G12 | T200 | 95 ± 11 |
| Antibody . | Antigen . | Binding . |
|---|---|---|
| . | . | (% of medium control)* . |
| MEL-14 | L-selectin | 19 ± 4 |
| PS/2 | α4 integrin | 94 ± 12 |
| FD441.8 | CD11a | 63 ± 6 |
| M1/70 | CD11b | 45 ± 6 |
| M18/2.a.8 | CD18 | 56 ± 15 |
| L11 | CD43 | 29 ± 6 |
| RB6-8C5 | PMN | 112 ± 23 |
| 30G12 | T200 | 95 ± 11 |
The binding of WEHI78/24 to HEV in CFA-inflamed lymph nodes in the presence of MoAb. Values are mean ± standard error of the percentage of binding in the presence of medium alone (N = 3).